- 专利标题: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
-
申请号: US18329986申请日: 2023-06-06
-
公开(公告)号: US12110297B2公开(公告)日: 2024-10-08
- 发明人: Jayanthy Jayanth , Mohamed-Eslam F. Mohamed , Ahmed A. Othman , Patrick J. Marroum , Peter T. Mayer , Ben Klünder
- 申请人: AbbVie Inc.
- 申请人地址: US IL North Chicago
- 专利权人: AbbVie Inc.
- 当前专利权人: AbbVie Inc.
- 当前专利权人地址: US IL North Chicago
- 代理机构: WOMBLE BOND DICKINSON (US) LLP
- 代理商 Danielle L. Herritt; Scott R. Breining
- 分案原申请号: US18174738 2023.02.27
- 主分类号: C07D487/14
- IPC分类号: C07D487/14 ; A61K9/00 ; A61K31/4985 ; A61K47/02 ; A61K47/12 ; A61K47/38 ; C07D487/04
摘要:
The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
公开/授权文献
信息查询